Lexeo Therapeutics, Inc. · NASDAQ:LXEO
Orbimed Advisors LLC reported a 4.10% stake in Lexeo Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 14, 2026
Orbimed Advisors LLC reported a 4.10% stake in Lexeo Therapeutics, Inc., 3,203,050 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G).
- Stake
- 4.10%
- Shares
- 3,203,050
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| OrbiMed Advisors LLC | 4.10% | 3,203,050 |
| OrbiMed Capital LLC | 1.00% | 744,800 |
Source
Related
- Lexeo Therapeutics, Inc.
- Orbimed Advisors LLC
- Lexeo Therapeutics, Inc. shareholders
- Schedule 13G · JPMorgan Chase & Co · Oct 13, 2026
- Form 4 · Bhalla Narinder Pal · Sep 28, 2026
- Form 4 · Otero Jose Manuel · Sep 28, 2026
- Form 4 · Townsend Richard Nolan · Sep 28, 2026
- Form 4 · Tamayo Louis Edward · Aug 19, 2026